$17.11
-0.95 (-5.26%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+27.31%
YTD
-7.51%
Open$18.07
Previous Close$18.06
Day High$18.15
Day Low$16.96
52W High$27.31
52W Low$11.92
Volume—
Avg Volume4.51M
Market Cap3.37B
P/E Ratio—
EPS$-3.33
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$18.16
Below
SMA 200
$14.91
Above
RSI (14)
28.7
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
21 analysts
Price Target
+471.9% upside
Current
$17.11
$17.11
Target
$97.86
$97.86
$76.65
$97.86 avg
$132.93
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 618.44M | 584.19M | 668.57M |
| Net Income | 86.92M | 95.40M | 98.23M |
| Profit Margin | 14.1% | 16.3% | 14.7% |
| EBITDA | 124.54M | 120.89M | 157.55M |
| Free Cash Flow | 66.24M | 92.85M | 89.99M |
| Rev Growth | +16.5% | -3.4% | +9.6% |
| Debt/Equity | 0.27 | 0.23 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $264.73 | +0.29% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $392.34 | +1.73% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.59 | +0.99% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $511.29 | +0.58% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $794.14 | +1.18% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $244.64 | +2.12% | 40.0 | 32.33B |